The concept of HSD10 inhibition as a potential treatment for HSD10 overexpression associated with Alzheimer’s disease pathology was introduced many years ago [10, 24, 38, 44]. This evidence concerns the gene FSIP1 and early-onset autosomal dominant Alzheimer disease.